Cardinal pays $1.1 billion for nuclear pharmacy unit
This article was originally published in Clinica
Executive Summary
Healthcare supply company Cardinal Health is to buy nuclear pharmacy company Syncor International for around $1.1bn in a share deal, including over $200m in debt assumption.